Cure8

Why This Matters

The study suggests molecular targets and pathways through which a traditional herbal formula might influence UC biology, offering testable hypotheses for future lab and clinical research.

Who Should Pay Attention

Researchers, clinicians, and drug-discovery teams interested in herbal medicines, molecular mechanisms of UC, or multi-target therapeutic strategies.

Study Snapshot

Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract

What To Know

The paper screened active compounds from SKD and predicted 94 shared targets between SKD and UC. Key hub proteins included AKT1, TNF, and TP53, and pathway analysis highlighted PI3K‑Akt and MAPK signaling.

Molecular docking and 100‑ns molecular dynamics simulations suggested stable binding for some compound–target pairs (for example, kaempferol with TNF and β‑sitosterol with AKT1) while others were less stable.

These results are computational and hypothesis-generating: they propose molecular interactions and pathways that might explain SKD's reported effects but do not provide clinical evidence of efficacy or safety.

Keep In Mind

Results are from computational analyses (network pharmacology, molecular docking, molecular dynamics). They do not demonstrate clinical benefit or safety and require experimental and clinical validation.

Source Details

Review the original publication for the complete reporting, methods, and context.

Read Original Source
Research paper Evidence type derived from source or registry metadata.
PublicationCurrent computer-aided drug design
AuthorsWu X, He Z, Ren W +2 more
Study typeIm, journal article
Indexed viaEurope PMC
Source typeResearch paper
PublishedAug 21, 2026, 12:00 AM
Content availableJournal abstract

This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.

Related Reading

Browse latest news →